Radiofrequency Ablation Effective For Small Kidney Cancers

Combination of precision cancer medicines may represent new treatment strategy for advanced renal cell cancer.

Checkpoint inhibitor Inlyta combo heads to FDA approval-likely to become new standard treatment for renal cell cancer

First-Line Inlyta Active in Metastatic Kidney Cancer

Checkpoint Inhibitor Immunotherapy Combinations Improve Survival in Advanced Kidney Cancer – Should be the New Standard

The kinase inhibitor Cabometyx™ is effective treatment as initial and or second line treatment of advanced kidney cancer

Opdivo® approved by US FDA for treatment of advanced renal cell cancer.